Invivyd (IVVD) Scheduled to Post Quarterly Earnings on Thursday

Invivyd (NASDAQ:IVVD) will be releasing its earnings data before the market opens on Thursday, November 14th. Analysts expect Invivyd to post earnings of ($0.32) per share for the quarter.

Invivyd (NASDAQ:IVVD) last announced its quarterly earnings data on Wednesday, August 14th. The company reported ($0.40) EPS for the quarter, missing analysts’ consensus estimates of ($0.37) by ($0.03). The business had revenue of $2.26 million during the quarter, compared to analysts’ expectations of $4.91 million. On average, analysts expect Invivyd to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Invivyd Stock Performance

IVVD traded down $0.02 during mid-day trading on Thursday, reaching $1.02. The stock had a trading volume of 110,646 shares, compared to its average volume of 628,654. The stock has a market capitalization of $121.83 million, a P/E ratio of -0.57 and a beta of 0.65. The firm’s fifty day simple moving average is $0.99 and its two-hundred day simple moving average is $1.35. Invivyd has a 52 week low of $0.81 and a 52 week high of $5.20.

Analyst Ratings Changes

A number of brokerages have commented on IVVD. EF Hutton Acquisition Co. I upgraded Invivyd to a “strong-buy” rating in a research report on Wednesday, October 30th. HC Wainwright reissued a “buy” rating and issued a $15.00 target price on shares of Invivyd in a research note on Tuesday, October 29th.

About Invivyd

Invivyd, Inc, a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company developed INVYMAB, a platform that combines viral surveillance and predictive modeling with advanced antibody engineering.